← Back to screener

ZIMMER BIOMET HOLDINGS, INC. ZBH

Rank #392 · NYSE · $18.3B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
66.7
P/E
17.9
P/B
1.47
ROE
8.2%
Op. Margin
17.3%
Debt Ratio
71%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★★☆
Good

P/E 17.9x, P/B 1.47x. Ranks in the top 24% of the universe.

Profitability ★★★☆☆
Good

ROE 8.2%. Ranks in the top 38% of the universe.

Safety ★★★★☆
Good

Debt ratio 71%. Ranks in the top 30% of the universe.

Growth ★★★☆☆
Average

Revenue growth of 6.5% year over year. Ranks in the top 45% of the universe.

Valuation is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$1.0B$0.7B$5.8B–39
2012–$0.9B$0.6B$5.5B–54
2013–$1.0B$0.8B$5.9B–54
2014–$1.0B$0.8B$6.3B–52
2015–$1.1B$0.8B$6.5B–47
2016–$1.0B$0.7B$9.9B–175
2017–$0.5B$0.1B$9.7B–176
2018$7.7B$0.8B$0.3B$11.7B10.7122
2019$7.8B$0.8B$1.8B$11.3B10.2114
2020$7.9B$0.0B$-0.4B$12.4B0.499
2021$8.0B$1.1B$1.1B$12.2B14.3100
2022$6.1B$0.1B$-0.1B$12.7B1.485
2023$6.8B$0.9B$0.4B$12.0B12.675
2024$6.9B$0.7B$0.2B$12.5B10.072
2025$7.4B$1.3B$1.0B$12.5B17.371

← See the full screener